Atıf Formatları
Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

C. Boz And F. KIZILAY, "Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France," ECTRIMS 2017 , France, pp.327, 0

Boz, C. And KIZILAY, F. Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France. ECTRIMS 2017 , (France), 327.

Boz, C., & KIZILAY, F., Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France . ECTRIMS 2017 (pp.327). , France

Boz, Cavit, And FERAH KIZILAY. "Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France," ECTRIMS 2017, France,

Boz, Cavit And KIZILAY, FERAH. "Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France." ECTRIMS 2017 , France, pp.327

Boz, C. And KIZILAY, F. . "Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France." ECTRIMS 2017 , France, p.327.

@conferencepaper{conferencepaper, author={Cavit Boz And author={FERAH KIZILAY}, title={Real world efficacy and safety of Teriflunomide in patients with relapsing remitting Multipl Sclerosis.ECTRIMS 2017, Paris, France}, congress name={ECTRIMS 2017}, city={}, country={France}, year={0}, pages={327} }